Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at one-tenth of the original cost.

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

Discover 10 powerful lifestyle modifications that can prevent and potentially reverse type 2 diabetes naturally, from ...

The rise of GLP-1s, which were initially approved for diabetes management and later for obesity treatment, underscores this ...

Its findings were included in the company’s latest State of Type 2 Report, which explored ... development of better or more effective diabetes medications, and 57% who included early education ...

Generic formulations of metformin/glipizide and metformin/glibenclamide are also available. A generic formulation of metformin/rosiglitazone from Teva has received tentative approval from the US ...

Eli Lilly launches Mounjaro in India addressing diabetes-obesity crisis. Approved by CDSCO yet high costs limit accessibility ...

inhibitor indicted for use in the treatment of type-2 diabetes mellitus, chronic kidney disease (CKD) and chronic heart failure (HF). Alkem’s generic empagliflozin and its combinations are ...